HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorFenerbahce University
About this trial
The aim of this study is to investigate the effect of post-stroke sarcopenia on prognosis and clinical outcomes in patients with ischemic stroke and to compare the effects of High Intensity Interval Training (HIIT) and Moderate Intensity Continuous Training (MCIT) exercise programs on muscle mass, as well as on functional capacity, quality of life, and clinical outcomes.
Eligibility criteria
Qualifiers
First-ever stroke.
Age 18 years or older.
Diagnosis of ischemic stroke.
Stroke duration between 1-6 months (subacute phase).
Disqualifiers
Presence of hemispatial neglect.
History of recurrent stroke.
Presence of a psychiatric disorder.
Presence of orthopedic, neurological, or cardiopulmonary conditions that would contraindicate the planned exercise protocols.
Trial design
Treatments tested in this trial
- High-Intensity Interval Training (HIIT)
- Moderate-Intensity Continuous Training (MCIT)
Treatment groups
32 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov